Zineryt 40 mg/ml - 12 mg/ml cut. sol. (pwdr. + solv.) vial 1

Zineryt 30 lot

.

Therapeutic Indications:

treatment of acne, in particular the dominant form of papulo-pustular inflammatory phenomena.

Qualitative and quantitative composition:

Zineryt contains 40 mg / ml erythromycin in the form of a zinc complex.
For excipients, see List of excipients.

Pharmaceutical form:

Solution for cutaneous use.

Posology and method of administration:

2 x daily
Zineryt should be applied to the skin of the entire face or other affected areas ( not only the lesion itself) until the entire treatment area is covered (by this time is ± 0.5 ml required).
Zineryt is administered by the bottle upside down with the slanted applicator against the skin to keep it pressing gently moving back and forth. The outflow of Zineryt can be regulated by increase or decrease the pressure of the applicator against the skin. Let dry.
The usual treatment duration is 10 to 12 weeks. In most cases, a satisfactory improvement was observed.
After use, the bottle does not pass to other patients to prevent infection.

This is a medicine, no prolonged use without medical advice, keep away from children, read the leaflet carefully. Ask your doctor or pharmacist. In case of side effects, contact your doctor.

Contraindications:

Hypersensitivity to erythromycin or other macrolide antibiotics, zinc or any of the other ingredients of the product.

Special warnings and precautions for use:

Zineryt is for treatment of skin and should not be brought into contact with eyes or mucous membranes.
Cross Sensitization between macrolides may action.
Cross resistance with other antibiotics of the macrolide group and with lincomycin and clindamycin can occur.
Since the solubility of Zineryt based on a complex formation of the active ingredients in the ethanol-diisopropylsebacaat vehicle, any disruption of that relationship in the solution by dilution with water or other liquids or by adding other anti-acne agents result in a demixing.

Pregnancy and lactation:

Zineryt may, if known under the rule used during pregnancy and lactation.

Side effects:

first is sometimes the alcohol base of Zineryt a burning or stinging, desquamation or a slight redness on the skin are observed. This is temporary.
As with any substance on the skin is applied to each component of Zineryt a possible allergic reaction. Zineryt with applicator applied to the skin and causes no dry spots on the skin or clothes with those treated skin came into contact.

Effects on ability to drive and use machines:

Data not worried.

Overdose:

A prolonged overdose of Zineryt will probably have consequences for the skin: erythema and dehydration. The risk of systemic reactions resulting from such application is very low.
An occasional intake of the entire contents of a container Zineryt will mainly be characterized by acute toxicity of this present volume absolute alcohol (99 ± 21 ml % ethanol).

List of excipients:

Diisopropylsebacaat - Ethanol.

Interaction with other medicinal products and other forms of interaction:

Zineryt the skin may not come into contact with acid or alkali as the active ingredient erythromycin can be inactivated by these substances (salicylic acid, urea, etc.). Vitamin A acid has proved an exception. In severe forms of acne therapy may be combined with Zineryt eg local application of vitamin A acid or benzoyl peroxide or oral administration of tetracycline.
By simultaneous application of other topical anti-acne products must be careful because the irritation can worse, especially for products that encourage exfoliation.

Incompatibilities:

Zineryt the skin may not come into contact with acid or alkali as the active ingredient erythromycin by these substances can be inactivated (salicylic acid, urea, etc.). Vitamin A acid is an exception proved.